These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4566123)

  • 1. A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
    Bankier RG
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):44-7. PubMed ID: 4566123
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluspirilene in the treatment of chronic schizophrenic outpatients.
    St-Laurent J; Carle R; Domingue D
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 4. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long term neuroleptic therapy using fluspirilene and penfluridol].
    Haase HJ; Fischer D; Floru L; Frank T; Joseph K; Knaack M; Mohr W; Richter-Peill H; Steuer A; Wahl G; Walterbusch G; Zurborn R
    Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
    Zwanikken GJ; Remans B; Dewulf P; Amery W
    Acta Psychiatr Scand; 1971; 47(3):334-48. PubMed ID: 4946910
    [No Abstract]   [Full Text] [Related]  

  • 7. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
    Malm U; Perris C; Rapp W; Wedrén G
    Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients.
    Schiele BC; Janecek J; Zimmermann R
    Compr Psychiatry; 1969 Sep; 10(5):355-60. PubMed ID: 4389944
    [No Abstract]   [Full Text] [Related]  

  • 10. A factor analytic study of the action of some neuroleptics on chronic schizophrenic syndromes.
    Perris C; Hållberg B; Malm U; Wedrén G; Espvall M; Rapp W
    Acta Psychiatr Scand Suppl; 1974; 249():123-34. PubMed ID: 4607777
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
    Donlon PT; Meyer JE
    J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
    Russell N; Landmark J; Merskey H; Turpin T
    Can J Psychiatry; 1982 Nov; 27(7):593-6. PubMed ID: 7172160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of fluspirilene as a maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Can Psychiatr Assoc J; 1973 Oct; 18(5):415-9. PubMed ID: 4746145
    [No Abstract]   [Full Text] [Related]  

  • 16. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J; Frei M; Scharfetter Chr
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract]   [Full Text] [Related]  

  • 17. Trifluoperazine: a comparison between regular and high doses.
    Wijsenbeek H; Steiner M; Goldberg SC
    Psychopharmacologia; 1974 Apr; 36(2):147-50. PubMed ID: 4601554
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot trials with long-acting pipotiazine injections.
    Hakola A
    Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.